# Comparison of Two Formulations of Proellex for Vaginal Administration

> **NCT01962805** · PHASE1 · COMPLETED · sponsor: **Repros Therapeutics Inc.** · enrollment: 8 (actual)

## Conditions studied

- Comparison of 2 Different Formulations of 12 mg Proellex Vaginal Capsules

## Interventions

- **DRUG:** Proellex Formulation A
- **DRUG:** Proellex Formulation B

## Key facts

- **NCT ID:** NCT01962805
- **Lead sponsor:** Repros Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2014-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01962805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01962805, "Comparison of Two Formulations of Proellex for Vaginal Administration". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01962805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*